POET-II Trial: Shorter Antibiotic Course for Infective Endocarditis
The POET-II clinical trial has demonstrated that shortening intravenous antibiotic duration by two weeks is safe and effective for patients recovering from infective endocarditis, a potentially fatal heart valve infection. ... Read More